Rathbones Group PLC Sells 14,594 Shares of McKesson Corporation $MCK

Rathbones Group PLC lowered its stake in shares of McKesson Corporation (NYSE:MCK) by 26.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 41,175 shares of the company’s stock after selling 14,594 shares during the period. Rathbones Group PLC’s holdings in McKesson were worth $33,775,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in MCK. GGM Financials LLC purchased a new stake in shares of McKesson in the 3rd quarter valued at about $25,000. State of Wyoming purchased a new position in shares of McKesson during the second quarter worth about $29,000. Hopwood Financial Services Inc. bought a new position in shares of McKesson in the third quarter worth approximately $31,000. Board of the Pension Protection Fund bought a new position in shares of McKesson in the fourth quarter worth approximately $33,000. Finally, Vermillion & White Wealth Management Group LLC purchased a new stake in McKesson in the third quarter valued at approximately $33,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. The trade was a 45.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 3,592 shares of company stock worth $3,518,555 over the last quarter. Company insiders own 0.08% of the company’s stock.

McKesson Trading Up 0.1%

Shares of NYSE:MCK opened at $885.42 on Monday. The stock has a fifty day simple moving average of $912.57 and a two-hundred day simple moving average of $846.69. The stock has a market capitalization of $108.45 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 1.26 and a beta of 0.42. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter in the prior year, the firm posted $8.03 earnings per share. The business’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts predict that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were given a dividend of $0.82 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is presently 9.43%.

Analyst Upgrades and Downgrades

MCK has been the subject of several research analyst reports. TD Cowen lifted their price target on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Robert W. Baird set a $968.00 price target on McKesson in a research note on Wednesday, January 14th. Evercore reiterated an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Wall Street Zen upgraded shares of McKesson from a “hold” rating to a “buy” rating in a report on Sunday, March 22nd. Finally, Wells Fargo & Company lifted their target price on shares of McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.